Governance HBL - Hadasit Bio-Holdings Ltd

HDST-M

IL0010954050

Biotechnology & Medical Research

Market Closed - TEL AVIV STOCK EXCHANGE Other stock markets 15:24:55 11/06/2026 BST			5-day change	1st Jan Change
72.50 ^ILa	0.00%		0.00%	+133.87%

03-12	HBL - Hadasit Bio-Holdings Ltd Reports Earnings Results for the Full Year Ended December 31, 2025	CI
27/08/25	HBL - Hadasit Bio-Holdings Ltd Reports Earnings Results for the Half Year Ended June 30, 2025	CI

Executive Committee: HBL - Hadasit Bio-Holdings Ltd

Manager

Positions heldSince

Yoram Azulai

65 year

Chief Executive Officer	30/03/2020
Director of Finance/CFO	19/09/2015
Corporate Secretary	19/09/2015

Doron Cohen

55 year

Comptroller/Controller/Auditor

30/08/2015

Composition of the Board of Directors: HBL - Hadasit Bio-Holdings Ltd

Director

CommitteesSince

Tamar Raz

62 year

Chairman

28/03/2018

Orit Stav

55 year

Audit Committee	19/10/2022
Finance Committee	19/10/2022
Compensation Committee	02/05/2023
Governance Committee Chair	04/04/2021
Nominating Committee Chair	04/04/2021
Audit Committee Chair	02/05/2023

Nurit Tweezer-Zaks

60 year

Audit Committee	17/07/2021
Finance Committee	17/07/2021
Compensation Committee	17/07/2021

Doron Nevo

70 year

Audit Committee	28/07/2018
Finance Committee	28/07/2018
Compensation Committee	28/07/2018

Yuval Adar

54 year

Director/Board Member

18/07/2021

Asher Elhayany

74 year

Director/Board Member

25/12/2022

Erez Meltzer

68 year

Director/Board Member

04/07/2016

Merav Kaye

53 year

Director/Board Member

27/09/2014

Latest Appointments: HBL - Hadasit Bio-Holdings Ltd

11/03/24	CEO of Pakistan's largest bank picked to lead country out of economic crisis	RE
11/03/24	Pakistan's HBL CEO Aurangzeb resigns from bank, letter to bourse shows	RE
05/03/24	Chief of Pakistan's largest bank likely to be included in new finance team, sources say	RE

More news

Former Officers and Directors: HBL - Hadasit Bio-Holdings Ltd

Insider

Positions held

SinceUntil

Oren Levy

Director/Board Member

24/10/2015

24/12/2022

Elka Nir

Director/Board Member	25/05/2015	17/07/2021
Independent Dir/Board Member	25/05/2015	17/07/2018

Aviv Reisfeld

Director/Board Member

28/03/2018

28/03/2021

Michel Moise Habib

Chief Executive Officer

28/03/2018

30/03/2020

Michal Sapir

Director/Board Member	29/09/2010	06/01/2019
Independent Dir/Board Member	28/07/2009	06/01/2019

Baruch Halpert

Chairman

30/04/2016

30/11/2017

Doron Pinhas Birger

Director/Board Member	21/09/2011	21/09/2017
Chairman	21/09/2011	-
Independent Dir/Board Member	21/09/2011	21/09/2017

Yaakov Naparstek

Director/Board Member

25/03/2014

22/03/2017

Tamar Kfir

Chief Executive Officer

31/12/2013

30/04/2016

Hillel Galitzer

Chief Operating Officer

31/07/2010

31/01/2014

Liat Hadad Simhayoff

Director of Finance/CFO

31/05/2012

Doron Debbie

Director/Board Member

29/09/2010

Yaron Kulas

Director/Board Member	29/09/2010	-
Independent Dir/Board Member	29/03/2006	-

Ophir Shahaf

Chief Executive Officer

29/09/2010

Shlomo Mor-Yosef

Director/Board Member

29/09/2010

Raf Hofstein

Director/Board Member	18/09/2005	-
Chairman	29/09/2010	16/12/2014

Uri Ben-Or

Director of Finance/CFO

Adi Raveh

Director/Board Member

29/09/2010

G. Burrill

Director/Board Member

Ruth Arnon

Director/Board Member

Einat Zisman

Director/Board Member

Ehud S. Kokia

Director/Board Member

Yigal Erlich

Director/Board Member	-	-
Chairman	-	-

Zeev Bronfeld

Director/Board Member	-	-
Independent Dir/Board Member	-	-

Yuval Cohen

Chairman

Age distribution of managers

Parity Men Women

Male	8
Female	2

Of which Executive Committee

Male	2
Female	0

Of which Directors

Male	6
Female	2

HBL Hadasit Bio Holdings Ltd (Hadasit) is an investment company, a subsidiary of Hadassah Medical Organization (HMO). The Companyâ€™s subsidiaries enable research and development and promote intellectual property (IP) to the medical and biotechnological industries. The Company together with its strategic partners, has established a number of start-up companies, and is assigned to commercialize that IP either through granting a product license to biotechnological or pharmaceutical companies or via the creation of a subsidiary which operates in the premise of HMO. Hadasit is equipped with resources and capabilities required for composing and conducting the pre-clinical services and clinical studies, establishing start-up companies, offering product licensing and providing international consulting services. The Companyâ€™s framework serves to address investment in early-stage biotechnological star-ups, by distributing both risk and success amongst a number of companies.

Employees

Sector

Biotechnology & Medical Research

More about the company